EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification
Background
EUS is increasingly used in the diagnosis of chronic pancreatitis (CP). A number of publications in this field have used different EUS terminology, features, and criteria for CP, making it difficult to reproduce their findings and apply them in clinical practice. Moreover, traditional criteria such as the Cambridge classification for CP are arguably outdated and have lost their relevance.
Objective
Our purpose was to establish consensus-based criteria for EUS features of CP.
Design
Consensus study.
Main Outcome Measurements
Thirty-two internationally recognized endosonographers anonymously voted on terminology of EUS features, rank order, and category (major vs minor criteria). Consensus was defined as greater than two thirds agreement among participants.
Results
Major criteria for CP were (1) hyperechoic foci with shadowing and main pancreatic duct (PD) calculi and (2) lobularity with honeycombing. Minor criteria for CP were cysts, dilated ducts ≥3.5 mm, irregular PD contour, dilated side branches ≥1 mm, hyperechoic duct wall, strands, nonshadowing hyperechoic foci, and lobularity with noncontiguous lobules.
Limitation
Lack of broadly accepted reference standard.
Conclusion
In a complex disease such as CP that has no universally accepted reference standard, an EUS-based criterion for diagnosis can be determined by expert consensus opinion and the existing body of evidence. Here we present the new “Rosemont criteria” for the EUS diagnosis of CP.
Abbreviations: BMI, body mass index, CP, chronic pancreatitis, MPD, main pancreatic duct, MRI, magnetic resonance imaging, OR, odds ratio, PD, pancreatic duct, PFT, pulmonary function test, ROC, receiver-operating characteristic curve
To access this article, please choose from the options below
DISCLOSURE: The following author disclosed financial relationships relevant to this publication: M. Freeman has received fellowship support from Cook Endoscopy, Boston Scientific, and Hobbs Medical, as well as speaking honorarium from Boston Scientific. All other authors disclosed no financial relationships relevant to this publication. The consensus conference was made possible by educational grants from Olympus Corporation, Cook Endoscopy, Microvasive, Pentax, Solvay, and Boston Scientific to provide for meals, hotel accommodations, travel expenses (not exceeding coach class tickets), and honorariums of speakers and panel members. The sponsors had no role in the conduct of the meeting or the analysis of the article.
See CME section; p. 1350.
If you want to chat with an author of this article, you may contact him at lhernan@mcw.edu.
PII: S0016-5107(08)02339-0
doi:10.1016/j.gie.2008.07.043
© 2009 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
